Print friendly version
Corneal dystrophy Avellino type
Other Names for this Disease
- Avellino corneal dystrophy
- Combined granular-lattice corneal dystrophies
- Granular and lattice corneal dystrophies
- Granular corneal dystrophy type 2
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
On this page
There is no cure for this condition and treatment usually focuses on alleviating symptoms, especially when vision becomes significantly impaired. Penetrating keratoplasty, which is a surgical procedure where a damaged or diseased cornea is entirely replaced by donated corneal tissue (graft), can improve vision at least temporarily but deposits tend to recur. LASIK eye surgery has been reported to exacerbate the number and density of the eye opacities. Patients treated with phototherapeutic keratectomy (PRK), which is a surgical procedure that uses a laser to remove tissue from the cornea, may do better and can retain corneal clarity for a decade or more.
Last updated: 4/7/2011
- Corneal dystrophy, Avellino type. Online Mendelian Inheritance of Man (OMIM). June 2009; http://www.ncbi.nlm.nih.gov/omim/607541. Accessed 4/6/2011.
- Han KE, Kim T et al.. Eye & Contact Lens. 2010; http://www.ncbi.nlm.nih.gov/pubmed/20724852. Accessed 4/6/2011.
- Corneal dystrophy, Avellino type. Hereditary Ocular Disease. The University of Arizona. http://disorders.eyes.arizona.edu/disorders/corneal-dystrophy-avellino-type. Accessed 4/6/2011.
Clinical Trials & Research for this Disease
- The U.S. National Institutes of Health, through the National Library of Medicine, developed ClinicalTrials.gov to provide patients, family members, and members of the public with current information on clinical research studies. There is a study titled Screening Study for the Evaluation and Diagnosis of Potential Research Participants which may be of interest to you. To find this trial, click on the link above.